Treatment Outcomes With tDCS in Post-Stroke Aphasia

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2029

Conditions
Aphasia
Interventions
DEVICE

Active Transcranial Direct Current Stimulation with SLT

"Soterix Medical 1×1 transcranial Direct Current Stimulator for Clinical Trials (1x1 tDCS-CT).~Excitatory stimulation to the left hemisphere will be achieved through a 1x1 montage utilizing two carbon-rubber electrodes and 5x7 EASY pad sponges (A-tDCS \[excitatory\]left target; C-tDCS \[inhibitory\]right hemisphere). Each PWA will have a unique 5-digit tDCS program code for each treatment phase. One code will instruct the 1x1 tDCS-CT to administer active stimulation as describe above (i.e., 1.5 mA for 20 min). The other will administer 1.5 mA for only a few seconds to simulate active stimulation. SLT will consist of Semantic Feature Analysis, Phonological Component Analysis, and Verb Network Strengthening Treatment"

DEVICE

Sham Transcranial Direct Current Stimulation with SLT

Control condition in which only SLT is administered.Participant receives 1.5 mA for only a few seconds to simulate active stimulation, then the stimulation will cease. SLT will consist of Semantic Feature Analysis, Phonological Component Analysis, and Verb Network Strengthening Treatment

Trial Locations (1)

72205

RECRUITING

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER